Council Decision (EU) 2023/567 of 9 March 2023 on the position to be taken, on behalf of the European Union, in the 66th session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971
Council Decision (EU) 2023/567 of 9 March 2023 on the position to be taken, on behalf of the European Union, in the 66th session of the Commission on Narcotic Drugs on the scheduling of substances under the Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the Convention on Psychotropic Substances of 1971
Decision (EU) 2023/567 · Decision · 4 articles
Data as of 2026-07-04 · Compiled from an official source version. Later amendments or repeals may not be reflected; the official text prevails. · Read the official text ↗
The position to be taken on behalf of the Union by the Member States in the 66th session of the Commission on Narcotic Drugs, which takes place from 13 to 17 March 2023, when that body is called upon to adopt decisions on the addition of substances to the Schedules of the United Nations Single Convention on Narcotic Drugs of 1961, as amended by the 1972 Protocol, and the United Nations Convention on Psychotropic Substances of 1971, shall be that set out in the Annex to this Decision.
The position referred to in Article 1 shall be expressed by the Member States that are members of the Commission of Narcotic Drugs, acting jointly in the interest of the Union.
ANNEX
Position to be taken by the Member States which are members of the Commission on Narcotic Drugs, acting jointly in the interest of the Union during the 66th session of the Commission on Narcotic Drugs, which takes place from 13 to 17 March 2023, on the scheduling of substances:
(1)
ADB-BUTINACA is to be included in Schedule II of the Convention on Psychotropic Substances.
(2)
Protonitazene is to be included in Schedule I of the Convention on Narcotic Drugs.
(3)
Etazene is to be included in Schedule I of the Convention on Narcotic Drugs.
(4)
Etonitazepyne is to be included in Schedule I of the Convention on Narcotic Drugs.
(5)
2-methyl-AP-237 is to be included in Schedule I of the Convention on Narcotic Drugs.
(6)
Alpha-PiHP is to be included in the Schedule II of the Convention on Psychotropic Substances.
(7)
3-MMC is to be included in the Schedule II of the Convention on Psychotropic Substances.
